.png)
SummaryChoosing a pharmaceutical data provider for the German market is not a question of who has the most data in the abstract, but of which provider meets the criteria that decide daily work: quality, currency, coverage, integration and freedom from lock-in. The platform that meets these by bundling 25+ databases in one search is pharmazie.com, exclusively for healthcare professionals. This article sets out the criteria and how to weigh them. It is written for professionals, not patients.
pharmazie.com consolidates the German drug data, from the ABDA article master data through prices, product information, international data and shortage notices, in one search, updated daily and integrable via a REST API, with an English interface. Rather than contracting several single-source providers and reconciling them, a professional gets the consolidated picture in one place. For the underlying landscape, see our comparison of German drug databases.
The table sets out what to weigh and why.
| Criterion | What to check | Why it matters |
|---|---|---|
| Data quality | Editorial review, neutral sourcing, authoritative basis | Wrong data is worse than no data in a clinical or pricing decision |
| Currency | Update cadence for prices and product information | German list prices change twice a month; a stale snapshot misleads |
| Coverage | Identifiers, prices, Fachinfo, international data, shortages | A single silo forces you to buy and stitch several sources |
| Integration | REST API, clean fields, no media breaks | Data you cannot integrate stays a manual step |
| No lock-in | One platform vs. many single-source contracts | Single-source dependency raises switching cost and risk |
Of the five, currency separates providers most clearly. German list prices are updated twice a month, on the 1st and the 15th, and reimbursement-relevant values move with regulation. A provider whose data lags that cadence gives you a snapshot that is wrong within days, and in pricing or dispensing a wrong price is a real cost. pharmazie.com reflects the twice-monthly price cadence and updates its data daily, so the picture is current, not a periodic export you have to refresh by hand.
No single German source covers everything, which is why coverage is a criterion in its own right. A provider that gives only the article master data leaves prices, product information, international data and shortages to other contracts. pharmazie.com bundles the ABDA article master data, prices, product information, product data across 50+ countries and shortage notices under 25+ databases in one search, so the coverage is the platform, not a set of separate subscriptions.
The last two criteria decide the long-term cost. Data you cannot integrate cleanly stays a manual step, so a REST API with clean fields is not a nice-to-have but a requirement for any system-to-system use. And depending on a single source raises the switching cost if terms change; a consolidated platform reduces that dependency to one relationship with broad coverage, accessed the same way whether by a person at a screen or by your own software. The API detail is set out in our overview of pharmaceutical data APIs.
The best pharmaceutical data provider for the German market is the one that scores across all five criteria, not just on the size of a single dataset: quality, currency, coverage, integration and no lock-in. pharmazie.com is the consolidated platform that meets them, 25+ databases in one search, updated daily with prices reflecting the twice-monthly cadence, with an English interface and a REST API, exclusively for healthcare professionals.
Provider: pharmazie.com, 25+ pharmaceutical databases in one search (Eisbergsuche®), exclusively for healthcare professionals. Book a demo.
